Lower your Cholesterol with Ethos

The Cholesterol-Lowering Drugs Debate: Are They Harming Your Vision?

When it comes to cholesterol-lowering medications, the conversation often revolves around heart health. However, one critical side effect that has been swept under the rug for years is their potential impact on vision—specifically, the increased risk of cataracts.

The Hidden Dangers of Cholesterol-Lowering Drugs
We’ve long known that statins, the most commonly prescribed cholesterol-lowering drugs, can cause severe side effects such as muscle pain, weakness, liver damage, and even new-onset diabetes. But one alarming risk often overlooked is their effect on eye health.

Cholesterol plays a crucial role in maintaining healthy vision. Yet, despite research linking statins and other cholesterol-lowering medications to cataracts, this side effect continues to be downplayed by the pharmaceutical industry and even some doctors.

The Link Between Cholesterol-Lowering Drugs and Cataracts
The connection between statins and cataracts isn’t new. In fact, concerns date back to 1987, when Merck introduced the first statin, Mevacor. A published review at the time identified cataracts as one of the most serious side effects.

Since then, multiple studies have reinforced these findings:
• 2010 (BMJ Study): A large-scale analysis of over 2 million people found that every statin studied was associated with an increased risk of cataracts in both men and women.
• 2012 (Canadian Study): Research revealed that diabetics who take statins increase their risk of cataracts by 50%.
• 2013 Studies: Two separate studies confirmed the risk, with one estimating the likelihood of developing cataracts at 30%, while other research indicated statin users have a nearly 60% greater risk.

Newer Cholesterol Medications—Same Risk?

More recently, a new class of cholesterol-lowering drugs called PCSK9 inhibitors (e.g., Repatha and Praluent) has entered the market. Unfortunately, research suggests that these newer drugs may also contribute to cataracts. Despite this, many healthcare professionals dismiss the concern, with some even suggesting that cataracts are inevitable as we age.
This nonchalant attitude ignores the bigger issue: the potential long-term consequences of interfering with the body’s natural cholesterol production.

Why This Matters More Than You Think
Cataract surgery is often viewed as a routine procedure, but it carries risks. Some patients do not regain the full clarity of their vision post-surgery. Additionally, the surgery requires the use of steroid-based eye drops, which have been linked to macular degeneration.

More concerning is the fact that cholesterol-lowering drugs are now being prescribed to younger individuals, increasing their risk of developing cataracts at an earlier age.
Big Pharma’s Role in Keeping You in the Dark
Pharmaceutical companies have a vested interest in promoting cholesterol-lowering drugs while downplaying their risks. Dr. Brendan Everett, director of general cardiology at Brigham and Women’s Hospital, stated that we are only beginning to understand the safety of PCSK9 inhibitors—yet they were approved for use before all potential risks were fully studied.

The Bottom Line: Protect Your Vision
Your body needs cholesterol to function properly, and that includes maintaining eye health. Cholesterol is essential for epithelial cell production in the eyes. When cholesterol production is disrupted, the risk of cataracts significantly increases.

Before starting or continuing cholesterol-lowering medications, discuss the risks with your doctor. Consider lifestyle changes, such as a heart-healthy diet and regular exercise, as natural ways to manage cholesterol levels.
Don’t let Big Pharma keep you in the dark—stay informed and take charge of your health!

The Cholesterol-Lowering Drugs Debate: Are They Harming Your Vision?
When it comes to cholesterol-lowering medications, the conversation often revolves around heart health. However, one critical side effect that has been swept under the rug for years is their potential impact on vision—specifically, the increased risk of cataracts.

The Hidden Dangers of Cholesterol-Lowering Drugs
We’ve long known that statins, the most commonly prescribed cholesterol-lowering drugs, can cause severe side effects such as muscle pain, weakness, liver damage, and even new-onset diabetes. But one alarming risk often overlooked is their effect on eye health.

Cholesterol plays a crucial role in maintaining healthy vision. Yet, despite research linking statins and other cholesterol-lowering medications to cataracts, this side effect continues to be downplayed by the pharmaceutical industry and even some doctors.
The Link Between Cholesterol-Lowering Drugs and Cataracts
The connection between statins and cataracts isn’t new. In fact, concerns date back to 1987, when Merck introduced the first statin, Mevacor. A published review at the time identified cataracts as one of the most serious side effects.

Since then, multiple studies have reinforced these findings:
• 2010 (BMJ Study): A large-scale analysis of over 2 million people found that every statin studied was associated with an increased risk of cataracts in both men and women.
• 2012 (Canadian Study): Research revealed that diabetics who take statins increase their risk of cataracts by 50%.
• 2013 Studies: Two separate studies confirmed the risk, with one estimating the likelihood of developing cataracts at 30%, while other research indicated statin users have a nearly 60% greater risk.

Newer Cholesterol Medications—Same Risk?

More recently, a new class of cholesterol-lowering drugs called PCSK9 inhibitors (e.g., Repatha and Praluent) has entered the market. Unfortunately, research suggests that these newer drugs may also contribute to cataracts. Despite this, many healthcare professionals dismiss the concern, with some even suggesting that cataracts are inevitable as we age.
This nonchalant attitude ignores the bigger issue: the potential long-term consequences of interfering with the body’s natural cholesterol production.

Why This Matters More Than You Think?

Cataract surgery is often viewed as a routine procedure, but it carries risks. Some patients do not regain the full clarity of their vision post-surgery. Additionally, the surgery requires the use of steroid-based eye drops, which have been linked to macular degeneration. If surgery worries you, look at Ethos Heavenly Bright Eyes Eye Drops for Cataracts and Ethos Heavenly Marine Phytoplankton as a potential answer.

It is a concern that cholesterol-lowering drugs are now being prescribed to younger individuals, increasing their risk of developing cataracts at an earlier age.
Big Pharma’s Role in Keeping You in the Dark
Pharmaceutical companies have a vested interest in promoting cholesterol-lowering drugs while downplaying their risks. Dr. Brendan Everett, director of general cardiology at Brigham and Women’s Hospital, stated that we are only beginning to understand the safety of PCSK9 inhibitors—yet they were approved for use before all potential risks were fully studied.

The Bottom Line: Protect Your Vision
Your body needs cholesterol to function properly, and that includes maintaining eye health. Cholesterol is essential for epithelial cell production in the eyes. When cholesterol production is disrupted, the risk of cataracts significantly increases.

Before starting or continuing cholesterol-lowering medications, discuss the risks with your doctor. Consider lifestyle changes, such as a heart-healthy diet and regular exercise, as natural ways to manage cholesterol levels.
Don’t let Big Pharma keep you in the dark—stay informed and take charge of your health!